Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.

@article{Tripepi2011InflammationAA,
  title={Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.},
  author={Giovanni Tripepi and Francesco U S Mattace Raso and Eric J G Sijbrands and Mohamed Sidy Seck and Renke Maas and Rainer H Boger and Jacqueline C. M. Witteman and Francesco Rapisarda and Lorenzo Malatino and Francesca Mallamaci and Carmine Zoccali},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2011},
  volume={6 7},
  pages={1714-21}
}
BACKGROUND Endothelial dysfunction as assessed by asymmetric dimethylarginine (ADMA) and inflammation has been consistently linked to atherosclerosis, death, and cardiovascular (CV) events in ESRD patients. Inflammation amplifies the effect of ADMA on the severity of atherosclerosis in ESRD patients, but it is still unknown whether inflammation and ADMA interact in the high risk of death and CV events in this population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS In a cohort of 225… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
38 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 38 extracted citations

Similar Papers

Loading similar papers…